Multiple Sclerosis Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Treatment (Injectable agents, Oral Agents)
Report Code: TIPRE00004597 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Multiple Sclerosis is a disease related to brain and spinal cord in which the immune system attacks the protective sheath i.e. myelin that covers the nerve fibers and results in communication problems between the brain and the rest of the body.
MARKET DYNAMICS
The Multiple Sclerosis market is anticipated to grow in the forecast period owing to driving factors such as rising number of multiple sclerosis incidences, increasing initiatives from the government for favorable reimbursements, and rise in number of R&D activities of pharmaceutical companies. Nevertheless, high cost associated with therapeutics and side effects of the drugs may hamper the market growth during the forecast period.
MARKET SCOPE
The "Global Multiple Sclerosis Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Multiple Sclerosis market with detailed market segmentation by type and geography. The global Multiple Sclerosis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Multiple Sclerosis market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Multiple Sclerosis market is segmented on the basis of Treatment. Based on Treatment the market is segmented into injectable agents and Oral Agents. REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Multiple Sclerosis market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Multiple Sclerosis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Multiple Sclerosis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Multiple Sclerosis market in these regions.
MARKET PLAYERS
The reports cover key developments in the Multiple Sclerosis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Multiple Sclerosis Market are anticipated to lucrative growth opportunities in the future with the rising demand for Multiple Sclerosis in the global market. Below mentioned is the list of few companies engaged in the Multiple Sclerosis market.
The report also includes the profiles of key Multiple Sclerosis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Multiple Sclerosis is a disease related to brain and spinal cord in which the immune system attacks the protective sheath i.e. myelin that covers the nerve fibers and results in communication problems between the brain and the rest of the body.
MARKET DYNAMICS
The Multiple Sclerosis market is anticipated to grow in the forecast period owing to driving factors such as rising number of multiple sclerosis incidences, increasing initiatives from the government for favorable reimbursements, and rise in number of R&D activities of pharmaceutical companies. Nevertheless, high cost associated with therapeutics and side effects of the drugs may hamper the market growth during the forecast period.
MARKET SCOPE
The "Global Multiple Sclerosis Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Multiple Sclerosis market with detailed market segmentation by type and geography. The global Multiple Sclerosis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Multiple Sclerosis market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Multiple Sclerosis market is segmented on the basis of Treatment. Based on Treatment the market is segmented into injectable agents and Oral Agents. REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Multiple Sclerosis market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Multiple Sclerosis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Multiple Sclerosis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Multiple Sclerosis market in these regions.
MARKET PLAYERS
The reports cover key developments in the Multiple Sclerosis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Multiple Sclerosis Market are anticipated to lucrative growth opportunities in the future with the rising demand for Multiple Sclerosis in the global market. Below mentioned is the list of few companies engaged in the Multiple Sclerosis market.
The report also includes the profiles of key Multiple Sclerosis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Biogen Idec
- Novartis
- EMD Serono
- Sanofi
- Teva Pharmaceutical
- Bayer
- Pfizer
- Synthetic Biologic
- Active Biotech
- Opexa.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Multiple Sclerosis Market - By Treatment
1.3.2 Multiple Sclerosis Market - By Region
1.3.2.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. MULTIPLE SCLEROSIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MULTIPLE SCLEROSIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. MULTIPLE SCLEROSIS MARKET - GLOBAL MARKET ANALYSIS
6.1. MULTIPLE SCLEROSIS - GLOBAL MARKET OVERVIEW
6.2. MULTIPLE SCLEROSIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MULTIPLE SCLEROSIS MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. INJECTABLE AGENTS
7.3.1. Overview
7.3.2. Injectable agents Market Forecast and Analysis
7.4. ORAL AGENTS
7.4.1. Overview
7.4.2. Oral Agents Market Forecast and Analysis
8. MULTIPLE SCLEROSIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Multiple Sclerosis Market Overview
8.1.2 North America Multiple Sclerosis Market Forecasts and Analysis
8.1.3 North America Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.1.4 North America Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.1.4.1 United States Multiple Sclerosis Market
8.1.4.1.1 United States Multiple Sclerosis Market by Treatment
8.1.4.2 Canada Multiple Sclerosis Market
8.1.4.2.1 Canada Multiple Sclerosis Market by Treatment
8.1.4.3 Mexico Multiple Sclerosis Market
8.1.4.3.1 Mexico Multiple Sclerosis Market by Treatment
8.1.4.4 US Multiple Sclerosis Market
8.1.4.4.1 US Multiple Sclerosis Market by Treatment
8.2. EUROPE
8.2.1 Europe Multiple Sclerosis Market Overview
8.2.2 Europe Multiple Sclerosis Market Forecasts and Analysis
8.2.3 Europe Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.2.4 Europe Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Multiple Sclerosis Market
8.2.4.1.1 Germany Multiple Sclerosis Market by Treatment
8.2.4.2 France Multiple Sclerosis Market
8.2.4.2.1 France Multiple Sclerosis Market by Treatment
8.2.4.3 Italy Multiple Sclerosis Market
8.2.4.3.1 Italy Multiple Sclerosis Market by Treatment
8.2.4.4 Spain Multiple Sclerosis Market
8.2.4.4.1 Spain Multiple Sclerosis Market by Treatment
8.2.4.5 United Kingdom Multiple Sclerosis Market
8.2.4.5.1 United Kingdom Multiple Sclerosis Market by Treatment
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Multiple Sclerosis Market Overview
8.3.2 Asia-Pacific Multiple Sclerosis Market Forecasts and Analysis
8.3.3 Asia-Pacific Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.3.4 Asia-Pacific Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Multiple Sclerosis Market
8.3.4.1.1 Australia Multiple Sclerosis Market by Treatment
8.3.4.2 China Multiple Sclerosis Market
8.3.4.2.1 China Multiple Sclerosis Market by Treatment
8.3.4.3 India Multiple Sclerosis Market
8.3.4.3.1 India Multiple Sclerosis Market by Treatment
8.3.4.4 Japan Multiple Sclerosis Market
8.3.4.4.1 Japan Multiple Sclerosis Market by Treatment
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Multiple Sclerosis Market Overview
8.4.2 Middle East and Africa Multiple Sclerosis Market Forecasts and Analysis
8.4.3 Middle East and Africa Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.4.4 Middle East and Africa Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Multiple Sclerosis Market
8.4.4.1.1 South Africa Multiple Sclerosis Market by Treatment
8.4.4.2 Saudi Arabia Multiple Sclerosis Market
8.4.4.2.1 Saudi Arabia Multiple Sclerosis Market by Treatment
8.4.4.3 U.A.E Multiple Sclerosis Market
8.4.4.3.1 U.A.E Multiple Sclerosis Market by Treatment
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Multiple Sclerosis Market Overview
8.5.2 South and Central America Multiple Sclerosis Market Forecasts and Analysis
8.5.3 South and Central America Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.5.4 South and Central America Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Multiple Sclerosis Market
8.5.4.1.1 Brazil Multiple Sclerosis Market by Treatment
8.5.4.2 Argentina Multiple Sclerosis Market
8.5.4.2.1 Argentina Multiple Sclerosis Market by Treatment
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. MULTIPLE SCLEROSIS MARKET, KEY COMPANY PROFILES
10.1. BIOGEN IDEC
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. NOVARTIS
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. EMD SERONO
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. SANOFI
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. TEVA PHARMACEUTICAL
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. BAYER
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. PFIZER
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. SYNTHETIC BIOLOGIC
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. ACTIVE BIOTECH
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. OPEXA.
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Multiple Sclerosis Market - By Treatment
1.3.2 Multiple Sclerosis Market - By Region
1.3.2.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. MULTIPLE SCLEROSIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MULTIPLE SCLEROSIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. MULTIPLE SCLEROSIS MARKET - GLOBAL MARKET ANALYSIS
6.1. MULTIPLE SCLEROSIS - GLOBAL MARKET OVERVIEW
6.2. MULTIPLE SCLEROSIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MULTIPLE SCLEROSIS MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. INJECTABLE AGENTS
7.3.1. Overview
7.3.2. Injectable agents Market Forecast and Analysis
7.4. ORAL AGENTS
7.4.1. Overview
7.4.2. Oral Agents Market Forecast and Analysis
8. MULTIPLE SCLEROSIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Multiple Sclerosis Market Overview
8.1.2 North America Multiple Sclerosis Market Forecasts and Analysis
8.1.3 North America Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.1.4 North America Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.1.4.1 United States Multiple Sclerosis Market
8.1.4.1.1 United States Multiple Sclerosis Market by Treatment
8.1.4.2 Canada Multiple Sclerosis Market
8.1.4.2.1 Canada Multiple Sclerosis Market by Treatment
8.1.4.3 Mexico Multiple Sclerosis Market
8.1.4.3.1 Mexico Multiple Sclerosis Market by Treatment
8.1.4.4 US Multiple Sclerosis Market
8.1.4.4.1 US Multiple Sclerosis Market by Treatment
8.2. EUROPE
8.2.1 Europe Multiple Sclerosis Market Overview
8.2.2 Europe Multiple Sclerosis Market Forecasts and Analysis
8.2.3 Europe Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.2.4 Europe Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Multiple Sclerosis Market
8.2.4.1.1 Germany Multiple Sclerosis Market by Treatment
8.2.4.2 France Multiple Sclerosis Market
8.2.4.2.1 France Multiple Sclerosis Market by Treatment
8.2.4.3 Italy Multiple Sclerosis Market
8.2.4.3.1 Italy Multiple Sclerosis Market by Treatment
8.2.4.4 Spain Multiple Sclerosis Market
8.2.4.4.1 Spain Multiple Sclerosis Market by Treatment
8.2.4.5 United Kingdom Multiple Sclerosis Market
8.2.4.5.1 United Kingdom Multiple Sclerosis Market by Treatment
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Multiple Sclerosis Market Overview
8.3.2 Asia-Pacific Multiple Sclerosis Market Forecasts and Analysis
8.3.3 Asia-Pacific Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.3.4 Asia-Pacific Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Multiple Sclerosis Market
8.3.4.1.1 Australia Multiple Sclerosis Market by Treatment
8.3.4.2 China Multiple Sclerosis Market
8.3.4.2.1 China Multiple Sclerosis Market by Treatment
8.3.4.3 India Multiple Sclerosis Market
8.3.4.3.1 India Multiple Sclerosis Market by Treatment
8.3.4.4 Japan Multiple Sclerosis Market
8.3.4.4.1 Japan Multiple Sclerosis Market by Treatment
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Multiple Sclerosis Market Overview
8.4.2 Middle East and Africa Multiple Sclerosis Market Forecasts and Analysis
8.4.3 Middle East and Africa Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.4.4 Middle East and Africa Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Multiple Sclerosis Market
8.4.4.1.1 South Africa Multiple Sclerosis Market by Treatment
8.4.4.2 Saudi Arabia Multiple Sclerosis Market
8.4.4.2.1 Saudi Arabia Multiple Sclerosis Market by Treatment
8.4.4.3 U.A.E Multiple Sclerosis Market
8.4.4.3.1 U.A.E Multiple Sclerosis Market by Treatment
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Multiple Sclerosis Market Overview
8.5.2 South and Central America Multiple Sclerosis Market Forecasts and Analysis
8.5.3 South and Central America Multiple Sclerosis Market Forecasts and Analysis - By Treatment
8.5.4 South and Central America Multiple Sclerosis Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Multiple Sclerosis Market
8.5.4.1.1 Brazil Multiple Sclerosis Market by Treatment
8.5.4.2 Argentina Multiple Sclerosis Market
8.5.4.2.1 Argentina Multiple Sclerosis Market by Treatment
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. MULTIPLE SCLEROSIS MARKET, KEY COMPANY PROFILES
10.1. BIOGEN IDEC
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. NOVARTIS
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. EMD SERONO
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. SANOFI
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. TEVA PHARMACEUTICAL
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. BAYER
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. PFIZER
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. SYNTHETIC BIOLOGIC
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. ACTIVE BIOTECH
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. OPEXA.
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies
- Biogen Idec
- Novartis
- EMD Serono
- Sanofi
- Teva Pharmaceutical
- Bayer
- Pfizer
- Synthetic Biologic
- Active Biotech
- Opexa.
- Biogen Idec
- Novartis
- EMD Serono
- Sanofi
- Teva Pharmaceutical
- Bayer
- Pfizer
- Synthetic Biologic
- Active Biotech
- Opexa.